Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the molecular formula C11H20N2O9P2 and a molecular weight of 386.23 g/mol[1][5]. It is structurally related to pyridoxal phosphate (vitamin B6 phosphate derivatives), featuring a pyridine ring substituted with hydroxy, methyl, and phosphonomethoxy groups, linked via an aminoalkane chain to another phosphonic acid moiety. The compound appears in chemical databases as an experimental or research molecule; there are no records of clinical use or approved therapeutic indications. Its mechanism of action is not described in available sources, but its structure suggests it may act as an analog or inhibitor in vitamin B6-dependent enzymatic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on {3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic acid.